[1]蒋冰蕾 朱平宇 陈小彬 任亦星.超重对成年女性性功能的影响[J].中华肥胖与代谢病电子杂志,2015,1(03):146-149.[doi:10.3877//cma.j.issn.2095-9605.2015.03.008]
 Jiang Binglei,Zhu Pingyu,Chen Xiaobin,et al.Influence of overweight on adult female sexual dysfunction[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(03):146-149.[doi:10.3877//cma.j.issn.2095-9605.2015.03.008]
点击复制

超重对成年女性性功能的影响()
分享到:

《中华肥胖与代谢病电子杂志》[ISSN:2095-9605/CN:11-9362]

卷:
第1卷
期数:
2015年03期
页码:
146-149
栏目:
临床研究
出版日期:
2015-09-30

文章信息/Info

Title:
Influence of overweight on adult female sexual dysfunction
作者:
蒋冰蕾1 朱平宇2 陈小彬2 任亦星3
637000 南充,川北医学院附属医院超声科1,泌尿外科2,普外科3
Author(s):
Jiang Binglei1 Zhu Pingyu2 Chen Xiaobin2 Ren Yixing3.
1Department of Ultrasound, 2Department of Urology Surgery, 3Department of General Surgery, the Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China
关键词:
超重 肥胖症 性功能障碍
Keywords:
Overweight Obesity Sexual dysfunction
DOI:
10.3877//cma.j.issn.2095-9605.2015.03.008
摘要:
目的 探讨超重对成年女性性功能的影响。方法 本问卷调查对象为2014年10月至2015年3月在川北医学院附属医院体检中心登记体检的1 132例成年已婚女性。按照体质指数 (body mass index,BMI)是否高于25 kg/m?,将受访者分为体重超重组 (BMI 25~30 kg/m?)和体重正常组 (BMI 18~25 kg/m?)。体重超重组428例,平均年龄(33.7±1.5)岁,平均BMI (27.9±3.2)kg/m?;体重正常组704例,平均年龄(33.9±2.1)岁,平均BMI (21.3±2.9)kg/m?。所有受访者均签署知情同意书,符合医学伦理学规定。所有受访者均以接受女性性功能指数问卷表 (中国版)的形式接受调查,比较两组受访者性功能障碍的发生情况。两组资料的比较采用t检验或χ2检验。结果 所有受访者女性性功能障碍 (female sexual dysfunction,FSD)的患病率为44% (499/1 132),其中体重超重组FSD的患病率明显高于体重正常组FSD的患病率 (χ2=32.023,P<0.05);体重正常合并有FSD受访者的FSFI总分明显高于体重超重合并有FSD的受访者(t=10.848,P<0.05)。结论 体重超重是导致本地区成年女性性功能障碍的重要因素。
Abstract:
Objective To investigate the influence of overweight on adult female sexual dysfunction. Methods A total of 1 132 adult married women undergoing medical examinations in medical center of the Affiliated Hospital of North Sichuan Medical College between October 2014 and March 2015 were included in this questionnaire survey. These respondents were divided into the overweight group (BMI 25~30 kg/m?) and the normal weight group (BMI 18-25 kg/m?) according to their BMI. Four hundred and twenty eight respondents were included into the overweight group with an average age of (33.7±1.5) years old and an average BMI of (27.9±3.2) kg/m?. Seven hundred and four respondents were included into the normal weight group with an average age of (33.9±2.1) years old and an average BMI of (21.3±2.9) kg/m?. The informed consents of all respondents were obtained and the local ethical committee approval had been received. All respondents were surveyed by the Chinese Version of Female Sexual Function Index (FSFI). The conditions of female sexual dysfunction of the two groups were compared. The data of the two groups were compared using t test and χ2 test. Results The prevalence rate of female sexual dysfunction (FSD) in the whole respondents was 44% (499/1 132), and the rate in overweight group was significantly higher than that in normal weight group (χ2=32.023,P<0.05). The FSFI score of normal weight respondents with FSD was significantly higher than that of overweight respondents with FSD (t=10.848,P<0.05). Conclusion Overweight was an important risk factor for adult female sexual dysfunction in the local area.

参考文献/References:

[1] van Hout GC, Verschure SK, van Heck GL. Psychosocial predictors of success following bariatric surgery[J]. Obes Surg, 2005, 15(4):552-560.
[2] Callegari A, Michelini I, Sguazzin C, et al. Efficacy of the SF-36 questionnaire in identifying obese patients with psychological discomfort[J].Obes Surg, 2005, 15(2):254-260.
[3] Camps MA, Zervos E, Goode S, et al. Impact of bariatric surgery on body image perception and sexuality in morbidly obese patients and their partners[J]. Obes Surg, 1996, 6(4):356-360.
[4] Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia[J]. Obes Res, 2000, 8(9):605-619.
[5] Ma J, Pan L, Lei Y, et al. Prevalence of female sexual dysfunction in urban Chinese women based on cutoff scores of the Chinese version of the female sexual function index: a preliminary study[J].J Sex Med, 2014, 11(4):909-919.
[6] Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index(FSFI): a multidimensional self-report instrument for the assessment of female sexual function[J]. J Sex Marital Ther, 2000, 26(2):191-208.
[7] Sun X, Li C, Jin L, et al. Development and validation of Chinese version of female sexual function index in a Chinese population~a pilot study[J]. J Sex Med, 2011, 8(4):1101-1111.
[8] Burri AV, Cherkas LM, Spector TD. The genetics and epidemiology of female sexual dysfunction: a review[J]. J Sex Med, 2009, 6(3):646-657.
[9] Kolotkin RL, Meter K, Williams GR. Quality of life and obesity[J]. Obes Rev, 2001, 2(4):219-229.
[10] Mozafari M, Khaiavikhan J, Jaafarpour M, et al. Association of body weight and female sexual dysfunction: a case control study[J]. Iran Red Crescent Med J, 2015, 17(1):e24685.
[11] Kirchengast S, Hartmann B, Gruber D, et al. Decreased sexual interest and its relationship to body build in postmenopausal women[J]. Maturitas, 1996, 23(1):63-71.
[12] Trischitta V. Relationship between obesity-related metabolic abnormalities and sexual function[J]. J Endocrinol Invest, 2003, 26(3 Suppl):62-64.
[13] Reviriego C. Flibanserin for female sexual dysfunction[J]. Drugs Today(Barc), 2014, 50(8):549-556.
[14] Assimakopoulos K, Panayiotopoulos S, Iconomou G, et al. Assessing sexual function in obese women preparing for bariatric surgery[J]. Obes Surg, 2006, 16(8):1087-1091.
[15] Dziurowicz-Kozlowska A, Lisik W, Wierzbicki Z, et al. Health-related quality of life after the surgical treatment of obesity [J]. J Physiol Pharmacol, 2005, 56(Suppl 6):127-134.

相似文献/References:

[1]徐田磊 秦超 白日星.减肥手术的研究进展[J].中华肥胖与代谢病电子杂志,2016,2(01):7.[doi:10.3877//cma.j.issn.2095-9605.2016.01.002]
[2]褚薛慧 单晓东 邱晨 邓玲 孙喜太.多学科诊疗模式在代谢手术中的应用价值[J].中华肥胖与代谢病电子杂志,2016,2(01):12.[doi:10.3877//cma.j.issn.2095-9605.2016.01.003]
 Chu Xuehui,Shan Xiaodong,Qiu chen,et al.Application value of multidisciplinary treatment mode in metabolic surgery[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2016,2(03):12.[doi:10.3877//cma.j.issn.2095-9605.2016.01.003]
[3]陈宏 雒洪志 周小雕 余元龙 梁义 王存川.腹腔镜Roux-en-Y 胃旁路术在治疗肥胖型2 型糖尿病中的应用价值[J].中华肥胖与代谢病电子杂志,2016,2(01):26.[doi:10.3877//cma.j.issn.2095-9605.2016.01.006]
 Chen Hong,Luo Hongzhi,Zhou Xiaodiao,et al.Application value of laparoscopic Roux-en-Y gastric bypass in treating obese type 2 diabetes mellitus[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2016,2(03):26.[doi:10.3877//cma.j.issn.2095-9605.2016.01.006]
[4]施晨晔 常薪霞 颜红梅 卞华 周荻 楼文晖 秦新裕 高鑫 吴海福.代谢手术对肥胖伴或不伴2型糖尿病的疗效分析[J].中华肥胖与代谢病电子杂志,2015,1(02):76.[doi:10.3877/cma.j.issn.2095-9605.2015.02.006]
 Shi Chenye,Chang Xinxia,Yan Hongmei,et al.Curative effect analysis of metabolic surgery for obesity with or without type 2 diabetes mellitus[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(03):76.[doi:10.3877/cma.j.issn.2095-9605.2015.02.006]
[5]林懋全 王存川 杨景哥 张艺超.LRYGB和LSG治疗T2DM的疗效及对GLP-1 和Ghrelin水平的影响[J].中华肥胖与代谢病电子杂志,2015,1(02):80.[doi:10.3877/cma.j.issn.2095-9605.2015.02.007]
 Lin Maoquan,Wang Cunchuan,Yang Jingge,et al.Curative effects of LRYGB and LSG on T2DM and their influences on GLP-1 and Ghrelin[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(03):80.[doi:10.3877/cma.j.issn.2095-9605.2015.02.007]
[6]孙世波 陈晓宁.腹腔镜袖状胃切除术在减肥手术中的应用[J].中华肥胖与代谢病电子杂志,2015,1(03):118.[doi:10.3877//cma.j.issn.2095-9605.2015.03.002]
[7]李东玲 陈小燕 黄炯强 闫凤 崔立谦 雷建 陈远光 黄致锟.腹腔镜胃束带联合胃折叠术后一年随访研究[J].中华肥胖与代谢病电子杂志,2015,1(03):132.[doi:10.3877//cma.j.issn.2095-9605.2015.03.005]
 Li Dongling,Chen Xiaoyan,Huang Jiongqiang,et al.One-year follow-up study of adjustable gastric banded plication for the treatment of obesity and metabolic diseases[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(03):132.[doi:10.3877//cma.j.issn.2095-9605.2015.03.005]
[8]赵象文 关凯林 华伟 韩月峰 马育林 梁国仲.精准腹腔镜Roux-en-Y胃旁路术治疗肥胖型2型糖尿病的临床应用价值[J].中华肥胖与代谢病电子杂志,2015,1(03):142.[doi:10.3877//cma.j.issn.2095-9605.2015.03.007]
 Zhao Xiangwen,Guan Kailin,Hua Wei,et al.Clinical application value of precise laparoscopic Roux-en-Y gastric bypass for obese T2DM Zhao[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(03):142.[doi:10.3877//cma.j.issn.2095-9605.2015.03.007]
[9]关炳生 王存川.内镜下减肥手术的研究进展[J].中华肥胖与代谢病电子杂志,2015,1(03):153.[doi:10.3877//cma.j.issn.2095-9605.2015.03.010]
[10]秦晓光 白日星 宋茂民 闫文貌 汪鑫.胃收缩力调节器治疗2型糖尿病的研究进展[J].中华肥胖与代谢病电子杂志,2015,1(03):157.[doi:10.3877//cma.j.issn.2095-9605.2015.03.011]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81500396)
通讯作者:任亦星,Email:cra0009@163.com
更新日期/Last Update: 2015-11-30